{
  "zip": "EC4N 7BL",
  "sector": "Healthcare",
  "fullTimeEmployees": 429,
  "longBusinessSummary": "ADVANZ PHARMA Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates in two segments, ADVANZ PHARMA International and ADVANZ PHARMA North America. The ADVANZ PHARMA International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies. This segment's products include Macrobid/Macrodantin to treat bladder infections, such as cystitis and urinary tract infections; Eltroxin, levothyroxine sodium that treats patients with an underactive thyroid gland; Fucithalmic, a topical gel treatment for patients suffering with a bacterial infection of the surface lining of the front of the eye; Zapain, a combination of codeine phosphate and paracetamol for severe pain reliefs, such as back pain, toothache, severe sprains and strains, and pain after operations. The ADVANZ PHARMA North America segment provides Donnatal, which is used as adjunctive therapy for irritable bowel syndrome; Zonegran, an anti-seizure drug indicated for adjunctive therapy in the treatment of partial seizures in adults with epilepsy; Nilandron for the treatment of metastatic prostate cancer; Plaquenil for the treatment of lupus and rheumatoid arthritis; and Photofrin for the treatment of certain types of cancer. The company sells its products through direct sales and local distribution relationships. The company was formerly known as Concordia International Corp. and changed its name to ADVANZ PHARMA Corp. in November 2018. ADVANZ PHARMA Corp. is headquartered in London, the United Kingdom.",
  "city": "London",
  "phone": "44 2085 889 100",
  "country": "United Kingdom",
  "companyOfficers": [],
  "website": "http://www.advanzpharma.com",
  "maxAge": 1,
  "address1": "Capital House",
  "fax": "44 2085 889 200",
  "industry": "Drug Manufacturersâ€”Specialty & Generic",
  "address2": "1st Floor 85 King William Street",
  "previousClose": 4.14,
  "regularMarketOpen": 4.14,
  "twoHundredDayAverage": 4.0511727,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 5.01,
  "navPrice": null,
  "averageDailyVolume10Day": 1162,
  "totalAssets": null,
  "regularMarketPreviousClose": 4.14,
  "fiftyDayAverage": 4.7598786,
  "trailingAnnualDividendRate": null,
  "open": 4.14,
  "averageVolume10days": 1162,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": 1468368000,
  "beta": 0.317226,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 4.14,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 1399,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 245056640,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 13971,
  "priceToSalesTrailing12Months": 0.47809958,
  "dayLow": 4.14,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 1399,
  "fiftyTwoWeekHigh": 19.14,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 2.13,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 5.01,
  "exchange": "PNK",
  "shortName": "ADVANZ PHARMA CORP LTD (JY)",
  "longName": "ADVANZ PHARMA Corp. Limited",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "CXRXF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_248858755",
  "uuid": "a78ed60d-edaf-3e69-b375-7c24f8e37ebb",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 2.713,
  "beta3Year": null,
  "profitMargins": -0.19882,
  "enterpriseToEbitda": 6.036,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 48913500,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -1.392,
  "sharesShort": 6759,
  "sharesPercentSharesOut": 0.0395,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.14483,
  "netIncomeToCommon": -101906000,
  "trailingEps": -2.09,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": 10.4,
  "sharesShortPreviousMonthDate": 1523577600,
  "floatShares": 22649881,
  "enterpriseValue": 1390650880,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1536624000,
  "lastSplitFactor": "1:300",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": 1526342400,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": 0.0461,
  "sharesShortPriorMonth": 7039,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 4.14,
  "logo_url": "https://logo.clearbit.com/advanzpharma.com"
}